11/9/26 Accelerate RARE Working Group A: Beyond the Conventional Trial: A New Evidence Framework for Rare and Individualized Therapies (Dr. Janet Woodcock) Next Accelerate RARE Working Group B: Pediatric Trial Readiness Blueprint (Ron Bartek) You Might Also Like From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Myth-Busting Hybrid & Home-Based Trials: What’s Real, What’s Not and What Scales Practical Application of Bayesian Networks in Rare Disease Trials Pediatric Rare Disease Development: Evidence, Flexibility, and Regulatory Pathways Accelerated Pathways and Global Harmonization
11/9/26 Accelerate RARE Working Group A: Beyond the Conventional Trial: A New Evidence Framework for Rare and Individualized Therapies (Dr. Janet Woodcock) Next Accelerate RARE Working Group B: Pediatric Trial Readiness Blueprint (Ron Bartek) You Might Also Like From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment Myth-Busting Hybrid & Home-Based Trials: What’s Real, What’s Not and What Scales Practical Application of Bayesian Networks in Rare Disease Trials Pediatric Rare Disease Development: Evidence, Flexibility, and Regulatory Pathways Accelerated Pathways and Global Harmonization
